Neurostimulation for Neurogenic Bowel Dysfunction

Background. Loss of normal bowel function caused by nerve injury, neurological disease or congenital defects of the nervous system is termed neurogenic bowel dysfunction (NBD). It usually includes combinations of fecal incontinence, constipation, abdominal pain and bloating. When standard treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: J. Worsøe, M. Rasmussen, P. Christensen, K. Krogh
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/563294
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561526055108608
author J. Worsøe
M. Rasmussen
P. Christensen
K. Krogh
author_facet J. Worsøe
M. Rasmussen
P. Christensen
K. Krogh
author_sort J. Worsøe
collection DOAJ
description Background. Loss of normal bowel function caused by nerve injury, neurological disease or congenital defects of the nervous system is termed neurogenic bowel dysfunction (NBD). It usually includes combinations of fecal incontinence, constipation, abdominal pain and bloating. When standard treatment of NBD fails surgical procedures are often needed. Neurostimulation has also been investigated, but no consensus exists about efficacy or clinical use. Methods. A systematic literature search of NBD treated by sacral anterior root stimulation (SARS), sacral nerve stimulation (SNS), peripheral nerve stimulation, magnetic stimulation, and nerve re-routing was made in Pubmed, Embase, Scopus, and the Cochrane Library. Results. SARS improves bowel function in some patients with complete spinal cord injury (SCI). Nerve re-routing is claimed to facilitate defecation through mechanical stimulation of dermatomes in patients with complete or incomplete SCI or myelomeningocele. SNS can reduce NBD in selected patients with a variety of incomplete neurological lesions. Peripheral stimulation using electrical stimulation or magnetic stimulation may represent non-invasive alternatives. Conclusion. Numerous methods of neurostimulation to treat NBD have been investigated in pilot studies or retrospective studies. Therefore, larger controlled trials with well-defined inclusion criteria and endpoints are recommended before widespread clinical use of neurostimulation against NBD.
format Article
id doaj-art-bfbd8f497f9a4d36aba5f6978b05f6f6
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-bfbd8f497f9a4d36aba5f6978b05f6f62025-02-03T01:24:53ZengWileyGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/563294563294Neurostimulation for Neurogenic Bowel DysfunctionJ. Worsøe0M. Rasmussen1P. Christensen2K. Krogh3Department of Surgery P, Aarhus University Hospital, Tage-Hansen Gade, 8000 Aarhus, DenmarkDepartment of Neurosurgery, Aarhus University Hospital, 8000 Aarhus, DenmarkDepartment of Surgery P, Aarhus University Hospital, Tage-Hansen Gade, 8000 Aarhus, DenmarkNeurogastroenterology Unit, Department of Hepatology and Gastroenterology, Aarhus University Hospital, 8000 Aarhus, DenmarkBackground. Loss of normal bowel function caused by nerve injury, neurological disease or congenital defects of the nervous system is termed neurogenic bowel dysfunction (NBD). It usually includes combinations of fecal incontinence, constipation, abdominal pain and bloating. When standard treatment of NBD fails surgical procedures are often needed. Neurostimulation has also been investigated, but no consensus exists about efficacy or clinical use. Methods. A systematic literature search of NBD treated by sacral anterior root stimulation (SARS), sacral nerve stimulation (SNS), peripheral nerve stimulation, magnetic stimulation, and nerve re-routing was made in Pubmed, Embase, Scopus, and the Cochrane Library. Results. SARS improves bowel function in some patients with complete spinal cord injury (SCI). Nerve re-routing is claimed to facilitate defecation through mechanical stimulation of dermatomes in patients with complete or incomplete SCI or myelomeningocele. SNS can reduce NBD in selected patients with a variety of incomplete neurological lesions. Peripheral stimulation using electrical stimulation or magnetic stimulation may represent non-invasive alternatives. Conclusion. Numerous methods of neurostimulation to treat NBD have been investigated in pilot studies or retrospective studies. Therefore, larger controlled trials with well-defined inclusion criteria and endpoints are recommended before widespread clinical use of neurostimulation against NBD.http://dx.doi.org/10.1155/2013/563294
spellingShingle J. Worsøe
M. Rasmussen
P. Christensen
K. Krogh
Neurostimulation for Neurogenic Bowel Dysfunction
Gastroenterology Research and Practice
title Neurostimulation for Neurogenic Bowel Dysfunction
title_full Neurostimulation for Neurogenic Bowel Dysfunction
title_fullStr Neurostimulation for Neurogenic Bowel Dysfunction
title_full_unstemmed Neurostimulation for Neurogenic Bowel Dysfunction
title_short Neurostimulation for Neurogenic Bowel Dysfunction
title_sort neurostimulation for neurogenic bowel dysfunction
url http://dx.doi.org/10.1155/2013/563294
work_keys_str_mv AT jworsøe neurostimulationforneurogenicboweldysfunction
AT mrasmussen neurostimulationforneurogenicboweldysfunction
AT pchristensen neurostimulationforneurogenicboweldysfunction
AT kkrogh neurostimulationforneurogenicboweldysfunction